Presence of maternal anti-HBS antibodies does not influence hepatitis B vaccine response in Brazilian neonates

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 1, 2011, Pages 113-116

  Junqueira, Ana Luiza N ^a   Tavares, Viviane R ^a   Martins, Regina M B ^b   Frauzino, Kamilla V ^a   da Costa e Silva, Agabo M ^b   Rodrigues, Izolina M X ^b   Minamisava, Ruth ^a   Teles, Sheila A ^a  

^a Faculdade de Enfermagem   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Antibody response; Hepatitis B vaccine; Newborn infants

Indexed keywords

HEPATITIS B VIRUS;

EID: 79851474865     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000100018     Document Type: Article

References (25)

1. Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA 2008. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 57: 404-409.
2. Baldy JL, de Lima GZ, Morimoto HK, Reiche EM, Matsuo T, de Mattos ED, Sudan LC 2004. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination. Rev Inst Med Trop Sao Paulo 46: 103-107.
3. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP 2008. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 27: 881-885.
4. Boot HJ, van der Waaij LA, Schirm J, Kallenberg CG, van Steenbergen J, Wolters B 2009. Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure. J Hepatol 50: 426-431.
5. Boxall EH, A Sira J, El-Shuhkri N, Kelly DA 2004. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 190: 1264-1269.
6. CDC - Centers for Disease Control and Prevention 1985. Epidemiologic notes and reports suboptimal response to hepatitis B vaccine given by injection into buttock. MMWR Morb Mortal Wkly Rep 34: 105-108.
7. Duval B, Gilca V, Boulianne N, De Wals P, Massé R, Trudeau G, De Serres G 2005. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J 24: 213-218.
8. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ 2007. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 25: 6958-6964.
9. Hieu NT, Kim KH, Janowicz Z, Timmermans I 2002. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 20: 1803-1808.
10. Hu Y, Wu Q, Xu B, Zhou Z, Wang Z, Zhou YH 2008. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Vaccine 26: 6064-6067.
11. Ioshimoto LM, Rissato ML, Bonilha VS, Miyaki C, Raw II, Granovski N 1999. Safety and immunogenicity of hepatitis B vaccine Butang in adults. Rev Inst Med Trop Sao Paulo 41: 191-193.
12. ® recombinant vaccine in newborn children in South Brazil. Mem Inst Oswaldo Cruz 101: 551-553.
13. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo HS, Huang LM, Chen DS, Lee CY 2008. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 197: 1419-1426.
14. Luna EJ, Moraes JC, Silveira L, Salinas HS 2009. Efficacy and safety of the Brazilian vaccine against hepatitis B in newborns. Rev Saude Publica 43: 1014-1020.
15. Martins RM, Bensabath G, Arraes LC, Oliveira MLA, Miguel JC, Barbosa GG, Camacho LAB 2004. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B. Mem Inst Oswaldo Cruz 99: 865-871.
16. MS - Ministério da Saúde 2003. Programa Nacional de Imunizações 30 anos. Série C - projetos, programas e relatórios, MS, Brasília, 212 pp.
17. ® vaccine in adolescents from low income families in Central Brazil. Mem Inst Oswaldo Cruz 101: 251-256.
18. Pongpipat D, Suvatte V, Assateerawatts A 1989. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine. Asian Pac J Allergy Immunol 7: 37-40.
19. Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP 2007. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 120: 373-381.
20. Van Herck K, Van Damme P 2008. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J 27: 861-869.
21. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A 2002. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 325: 569.
22. WHO - World Health Organization 2008. Immunization surveillance, assessment and monitoring. Hepatitis B. Available from: http://www.who.int/immunization_monitoring/diseases/hepatitis/en/index.html.
23. WHO - World Health Organization 2009. Global immunization data. Available from: http://www.who.int/immunization/newsroom/GID_english.pdf.
24. Yang YJ, Liu CC, Chen TJ, Lee MF, Chen SH, Shih HH, Chang MH 2003. Role of hepatitis B immunoglobulin in infants born to hepatitis B antigen-negative carrier mothers in Taiwan. Pediatr Infect Dis J 22: 584-588.
25. Zanetti AR, Van Damme P, Shouval D 2008. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26: 6266-6273.